Loading
Gestational Diabetes Research and Management / Adipokines, Inflammation, and Metabolic Diseases · Journal article
Frontiers in Immunology · September 7, 2026
Raises a question worth testing. It does not answer one.
This is a narrative synthesis of mechanistic evidence linking pre-pregnancy obesity to gestational diabetes mellitus via immune dysregulation pathways. It does not present new empirical findings or resolve the mechanistic question; rather, it maps immunological hypotheses—including chronic inflammation, adipose tissue remodelling, and altered maternal–foetal immune tolerance—as potential explanations for the obesity-GDM association.
Journal article. Pregnant women with pre-pregnancy obesity at risk of gestational diabetes mellitus..
Pre-pregnancy obesity is associated with rising incidence of gestational diabetes mellitus, paralleling global obesity trends. Obesity is characterised by chronic, low-grade inflammation driven by adipose tissue expansion and immune cell infiltration. Immune dysregulation is proposed as a plausible mechanistic link between pre-pregnancy obesity and impaired metabolic adaptation during pregnancy.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize that obesity-associated GDM risk may involve multiple immune pathways beyond simple insulin resistance. This review identifies mechanistic targets but does not yet support specific preventive or diagnostic strategies based on immune biomarkers.
This is a narrative review synthesizing mechanistic pathways rather than reporting new empirical evidence; it raises questions about immune dysregulation linking obesity to GDM but does not present primary data or definitive evidence to answer them.
Clinicians should recognize that obesity-associated GDM risk may involve multiple immune pathways beyond simple insulin resistance. This review identifies mechanistic targets but does not yet support specific preventive or diagnostic strategies based on immune biomarkers.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Gestational diabetes mellitus (GDM) is a prevalent metabolic complication of pregnancy with rising global incidence. Its increasing prevalence parallels the rising rates of pre-pregnancy obesity worldwide. While physiological insulin resistance is a normal feature of pregnancy, excess maternal adiposity exacerbates this process and significantly increases the risk of GDM. Emerging evidence highlights immune dysregulation as a plausible mechanistic link between pre-pregnancy obesity and impaired metabolic adaptation during pregnancy. Obesity is characterised by chronic, low-grade inflammation, driven by adipose tissue expansion, immune cell infiltration, and dysregulated cytokine and adipokine production. These changes may collectively impair insulin signalling, disrupt placental function, and alter maternal–foetal immune tolerance. In this review, we synthesise current understanding of the immunological pathways connecting pre-pregnancy obesity to GDM, including alterations in innate and adaptive immune responses, soluble inflammatory mediators, and placental immune dynamics. By integrating metabolic and immunological perspectives, this narrative mini-review highlights potential mechanisms underpinning obesity-associated GDM and highlights critical gaps in knowledge relevant to early risk stratification and targeted prevention strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.